Krzysztof Brzozka
Directeur Technique/Scientifique/R&D chez RYVU THERAPEUTICS S.A.
Fortune : 3 M $ au 30/04/2024
Postes actifs de Krzysztof Brzozka
Sociétés | Poste | Début | Fin |
---|---|---|---|
RYVU THERAPEUTICS S.A. | Directeur Technique/Scientifique/R&D | 17/07/2014 | - |
Corporate Officer/Principal | 01/01/2007 | 17/07/2014 | |
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Krzysztof Brzozka
Formation de Krzysztof Brzozka
Uniwersytet Jagiellonski | Graduate Degree |
Ludwig-Maximilians-Universität München | Doctorate Degree |
Cracow University of Economics | Masters Business Admin |
Stockholm Business School | Masters Business Admin |
Statistiques
Internationale
Pologne | 5 |
Allemagne | 2 |
Suède | 2 |
Opérationnelle
Masters Business Admin | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 5 |
Health Technology | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
RYVU THERAPEUTICS S.A. | Health Technology |
Entreprise privées | 1 |
---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
- Bourse
- Insiders
- Krzysztof Brzozka
- Expérience